WoundReference improves clinical decisions
 Choose the role that best describes you
Ruocco E, Sangiuliano S, Gravina AG, Miranda A, Nicoletti G, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV. Date of publication 2009 Sep 1;volume 23(9):1008-17.
1. J Eur Acad Dermatol Venereol. 2009 Sep;23(9):1008-17. doi: 10.1111/j.1468-3083.2009.03199.x. Epub 2009 Mar 11. Pyoderma gangrenosum: an updated review. Ruocco E(1), Sangiuliano S, Gravina AG, Miranda A, Nicoletti G. Author information: (1)Department of Dermatology, Second University of Naples, Naples, Italy. Pyoderma gangrenosum is a rare, ulcerative, cutaneous condition. First described in 1930, the pathogenesis of pyoderma gangrenosum remains unknown, but it is probably related to a hyperergic reaction. There are various clinical and histological variants of this disorder. Pyoderma gangrenosum often occurs in association with a systemic disease such as inflammatory bowel disease, rheumatologic disease, paraproteinaemia, or haematological malignancy. The diagnosis, mainly based on the clinical presentation and course, is confirmed through a process of elimination of other causes of cutaneous ulcers. Local treatment may be sufficient for mild disease, while for severe cases, systemic immunosuppressants are the mainstay. Long-term treatment with these agents is often required, but this can expose patients to adverse side-effects. DOI: 10.1111/j.1468-3083.2009.03199.x PMID: 19470075 [Indexed for MEDLINE]
Appears in following Topics:
Pyoderma Gangrenosum - Treatment